Dusa Pharmaceuticals Inc trades in the stock market as ticker DUSA. Business Summary & Profile For Dusa Pharmaceuticals Inc.

Dusa Pharmaceuticals Inc

DUSA Pharmaceuticals, Inc., a vertically integrated dermatology company, develops and markets Levulan photodynamic therapy (PDT) and other products for common skin conditions primarily in the United States, Canada, and Korea. Its products include Levulan Kerastick 20% Topical Solution with PDT and the BLU-U brand light source for the treatment of non-hyperkeratotic actinic keratoses of the face or scalp. The company also markets the BLU-U without Levulan for the treatment of moderate inflammatory acne vulgaris and general dermatological conditions; and non-PDT drug products, such as ClindaReach and AVAR products. DUSA Pharmaceuticals, Inc. was founded in 1991 and is based in Wilmington, Massachusetts.
www.dusapharma.com
93 Employees
Last Reported Date: 11/10/11
Founded in 1991
LAST $5.00 USD
CHANGE TODAY +0.02 0.40%
VOLUME 65.0K
As of 5:20 PM 02/27/12 All times are local (Market data is delayed by at least 15 minutes).

Snapshot of DUSA PHARMACEUTICALS INC (DUSA)

OPEN
$4.98
PREVIOUS CLOSE
$4.98
DAY HIGH
$5.06
DAY LOW
$4.96
52 WEEK HIGH
06/2/11 - $6.83
52 WEEK LOW
02/28/11 - $2.95
MARKET CAP
123.2M
AVERAGE VOLUME 10 D
83.7K
EPS TTM
$0.26
SHARES OUTSTANDING
24.6M
DUSA Does Not Pay Dividends
P/E TTM
19.2x
K = Thousands  M = Millions  B = Billions

related news

No related news articles were found.

Key developments for DUSA PHARMACEUTICALS INC (DUSA)

DUSA Pharmaceuticals Inc. Presents at Biotechnology Industry Organization's 14th Annual BIO CEO & Investor Conference, Feb-14-2012 02:30 PM

DUSA Pharmaceuticals Inc. Presents at Biotechnology Industry Organization's 14th Annual BIO CEO & Investor Conference, Feb-14-2012 02:30 PM. Venue: Waldorf Astoria Hotel, 301 Park Avenue, New York, NY 10022, United States. Speakers: Robert F. Doman, Chief Executive Officer, President and Director.

DUSA Pharmaceuticals Inc. Presents at Leerink Swann LLC's 2012 Global Healthcare Conference, Feb-15-2012 01:30 PM

DUSA Pharmaceuticals Inc. Presents at Leerink Swann LLC's 2012 Global Healthcare Conference, Feb-15-2012 01:30 PM. Venue: The Waldorf Astoria, New York, New York, United States. Speakers: Richard C. Christopher, Chief Financial Officer, Principal Accounting Officer and Vice President of Finance, Robert F. Doman, Chief Executive Officer, President and Director.

DUSA Pharmaceuticals Inc. Presents at Canaccord Genuity Cardiovascular, Aesthetics & Metabolic Disorders Conference, Dec-06-2011 02:20 PM

DUSA Pharmaceuticals Inc. Presents at Canaccord Genuity Cardiovascular, Aesthetics & Metabolic Disorders Conference, Dec-06-2011 02:20 PM. Venue: St. Regis Hotel, 125 3rd Street, San Francisco, CA 94103, United States. Speakers: Robert F. Doman, Chief Executive Officer, President and Director.

DUSA Competitors

Company Last Change
Derma Sciences Inc $8.69 USD -0.26
Diomed Holdings Inc $0.0001 USD 0.00
Elite Pharmaceuticals Inc $0.10 USD 0.00
Lescarden Inc $0.04 USD -0.007
Tianyin Pharmaceutical Co Inc $0.75 USD -0.0105
Market data is delayed at least 15 minutes.
 

Industry Analysis

Valuation DUSA Industry Range
Price/Earnings 19.0x
Price/Sales 2.9x
Price/Book 5.0x
Price/Cash Flow 17.7x
TEV/Sales 2.3x

DUSA

 | 

DUSA transactions

Type
Date
Target
No transactions in the last 6 months.
No related news found for this Dusa Pharmaceuticals Inc.

Write Comment Create Account
Subject Author
Reports
Dusa Pharmaceuticals (NASDAQ: DUSA) reports first-quarter EPS of $0.08 versus the estimated $0.07 pe...
whalbaybeach
Management Comments:
...
whalbaybeach
Survived
Well, they beat on revs and on earnings, at least on non-GAAP earnings. Those warrants are still ar...
dusa1957
in a down market it's nice to see an 8.5% pop
volume picking up, demand. Anyone sniffing around HQ...
Dean4614
STOCK PRICE
The shorts are having a field day. how low do we go. any thoughts....
cityfarmernot
Sold more today in the 6.4 to 6.6 range
I sold all I had re-bought near 5.5, plus sold more of my original position from before last earning...
dusa1957
8-K filing: amended and restated employment agreements
"The new agreements include, among other items, changes to the calculation of payments that...
Rincon_PR
What do you think about this news for DUSA Pharmaceuticals Inc.
You have to see the news for DUSA Pharmaceuticals Inc.) released today! <a href="HTTP:/...
alfredabarragand6401
Yahoo Finance's Erroneous Earnings Reporting
...
c.cooper1@sbcglobal.net
DUSA 42% Upside to hit 7.7 Consensus Target
based on DUSA summary sheet on yahoo financials page....
pro_stock_picker
Could be the best time to buy DUSA Pharmaceuticals Inc.
Wow, check this out, bullish technicals all the way on DUSA Pharmaceuticals Inc. <a href=&qu...
pamwirkkalabt4876
Could be the best time to buy DUSA Pharmaceuticals
Woah guys, this is interesting stuff for DUSA Pharmaceuticals <a href="HTTP://WWW.BES...
astridisd880
anyone know if they were suppose to present today
shows on sked to speak. Anyone?...
Dean4614
Big Jump in Medicare Re-imbursement
Effective July 1 2012 the Medicare reimbursement for J7308 (Levulan Kerastick will be 161.83 represe...
skincancersurgery
Moving up on low volume
Good steady movement up on low volume over the last month. Perhaps in anticipation go a good second...
dermscience
Selling shares bought at 4.8 to 5.2 now
I want to unload ahead of earnings report. This should be their seasonally bad Q, and last Q it was...
dusa1957
EARNINGS RELEASE
WHERE is everybody...
cityfarmernot
Yahoo Finance Mis-Reported DUSA's 1st Qtr Results
Used GAAP figures instead of non-GAAP.......
c.cooper1@sbcglobal.net
Doman was predictable...
He did just what I thought he would do when I sold out over a year ago. Namely, he&#39;s spendi...
crazyworld4u
Warrants
The stock has gone down since earnings and this may be due to disappointing revenues. Although the ...
jmj66666
BUY or SELL
Is Dusa now a BUY or SELL THANK-YOU...
cityfarmernot
Where is everybody
???????????????...
burgoo
New Clinical Data Longs!
Excellent new data out. Occlusive delivery of the ALA is going to really help those with AKs on the...
dermscience
dusa volume breakout 6.2-6.5
based on operational market news announcements and trading volume patterns....
econ_recovering2009
DUSA Consensus 2013 75% Profit Growth
As listed in Fidelity research &quot;key statistics&quot; page for forecasted profit....
frankly_buying

Quotes are delayed for NASDAQ, NYSE, OTC, OTCBB (Penny Stocks) and NYSE Amex when available. Quotes and other information supplied by independent providers and feeds. All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Localnewsnor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing Localnews, you agree not to redistribute the information found therein.

Privacy Policy - WE KEEP YOUR PERSONAL DATA PRIVATE AND CONFIDENTIAL - Localnews is committed to protecting the privacy of all our visitors and subscribers. Your right to privacy is very important to us. When you choose to provide us with information about yourself, we recognize that you trust us to act in a responsible manner. SHARING OF INFORMATION - Localnews does not sell, rent, lease or share any user information that it has collected over this website.

@2012 www.localnewsnow.org - Contact Us / Privacy Policy